Archives

In cancer treatment, time is of critical importance. According to the American Cancer Society, an estimated 42% of all cancer cases in the U.S., as well as roughly 45% of cancer deaths, can be [...]

By Danielle M. Quintanilha, PhD Cancer is not only a deeply devastating disease for patients and their families, but is cited as the second leading cause of death (29%) in the country, second [...]

By Rachel Wellinghoff Disease is complex. This statement seems so evident, but behind it lies an entirely new way to approach oncology. Previous methods have targeted single analytes, prescribing [...]

Tumor-infiltrating lymphocytes (TILs) are lymphocytes that directly infiltrate the tumor microenvironment (TME) opposing or surrounding tumor cells and in some cases subsets of cancer-reactive [...]

CAMBRIDGE, MA, Mar. 4, 2020 (REPORTABLE) – Video methods for the molecular protocol associated with the Cofactor Genomics ImmunoPrism® Assay are now published in the Journal of Visualized [...]

SAN FRANCISCO, Feb. 28, 2020 (CLINICAL OMICS) – A retrospective study among head and neck cancer patients found that a multivariate RNA biomarker test performed equally as standard PD-L1 [...]

By Zachary Bradley   Cell Surface Markers The human body is a complex environment made up of many different types of cells interacting with one another as well as their environment. In order [...]

By Kevin Flanagan, PhD Oncologists and cancer patients alike carefully track tumor status. The tumor is growing. The tumor is shrinking. The tumor has spread. The tumor is stable. There are new [...]

SAN FRANCISCO, Feb. 7, 2020 (DIAGNOSTIC WORLD) – Achieving true precision medicine in oncology continues to challenge the entire healthcare field—from clinicians to drug manufacturers to [...]